These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27260315)

  • 1. Neprilysin and Natriuretic Peptide Regulation in Heart Failure.
    Bayes-Genis A; Morant-Talamante N; Lupón J
    Curr Heart Fail Rep; 2016 Aug; 13(4):151-7. PubMed ID: 27260315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides.
    D'Elia E; Iacovoni A; Vaduganathan M; Lorini FL; Perlini S; Senni M
    Eur J Heart Fail; 2017 Jun; 19(6):710-717. PubMed ID: 28326642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current role of neprilysin inhibitors in hypertension and heart failure.
    von Lueder TG; Atar D; Krum H
    Pharmacol Ther; 2014 Oct; 144(1):41-9. PubMed ID: 24836726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Angiotensin Receptor-Neprilysin Inhibition in Heart Failure.
    Prenner SB; Shah SJ; Yancy CW
    Curr Atheroscler Rep; 2016 Aug; 18(8):48. PubMed ID: 27324636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin Receptor-Neprilysin Inhibitors and the Natriuretic Peptide Axis.
    Vasquez N; Carter S; Grodin JL
    Curr Heart Fail Rep; 2020 Jun; 17(3):67-76. PubMed ID: 32394149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Progress and Knowledge Basis on the Natriuretic Peptide System in Heart Failure.
    Fu S; Chang Z; Luo L; Deng J
    Curr Top Med Chem; 2019; 19(20):1850-1866. PubMed ID: 31448711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of neprilysin inhibitor combinations in hypertension: insights from hypertension and heart failure trials.
    Bavishi C; Messerli FH; Kadosh B; Ruilope LM; Kario K
    Eur Heart J; 2015 Aug; 36(30):1967-73. PubMed ID: 25898846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Body Mass Index on the Accuracy of N-Terminal Pro-Brain Natriuretic Peptide and Brain Natriuretic Peptide for Predicting Outcomes in Patients With Chronic Heart Failure and Reduced Ejection Fraction: Insights From the PARADIGM-HF Study (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial).
    Nadruz W; Claggett BL; McMurray JJ; Packer M; Zile MR; Rouleau JL; Desai AS; Swedberg K; Lefkowitz M; Shi VC; Prescott MF; Solomon SD
    Circulation; 2016 Nov; 134(22):1785-1787. PubMed ID: 27895026
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic options of Angiotensin Receptor Neprilysin inhibitors (ARNis) in chronic heart failure with reduced ejection fraction: Beyond RAAS and sympathetic nervous system inhibition.
    Volterrani M; Iellamo F; Senni M; Piepoli MF
    Int J Cardiol; 2017 Jan; 226():132-135. PubMed ID: 27184730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of neutral endopeptidase (neprilysin) inhibition on the response to other vasoactive peptides in small human resistance arteries: studies with thiorphan and omapatrilat.
    Dalzell JR; Seed A; Berry C; Whelan CJ; Petrie MC; Padmanabhan N; Clarke A; Biggerstaff F; Hillier C; McMurray JJ
    Cardiovasc Ther; 2014 Feb; 32(1):13-8. PubMed ID: 24138103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ARNi: A Novel Approach to Counteract Cardiovascular Diseases.
    Volpe M; Rubattu S; Battistoni A
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Novel Multi-target Inhibitor of angiotensin type 1 receptor and neprilysin inhibitors from Traditional Chinese Medicine.
    Huo X; Qiao L; Chen Y; Chen X; He Y; Zhang Y
    Sci Rep; 2019 Nov; 9(1):16205. PubMed ID: 31700033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual inhibition of ACE and NEP provides greater cardioprotection in mice with heart failure.
    Xu J; Carretero OA; Liu YH; Yang F; Shesely EG; Oja-Tebbe N; Yang XP
    J Card Fail; 2004 Feb; 10(1):83-9. PubMed ID: 14966779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barcelona Bio-HF Calculator Version 2.0: incorporation of angiotensin II receptor blocker neprilysin inhibitor (ARNI) and risk for heart failure hospitalization.
    Lupón J; Simpson J; McMurray JJV; de Antonio M; Vila J; Subirana I; Barallat J; Moliner P; Domingo M; Zamora E; Bayes-Genis A
    Eur J Heart Fail; 2018 May; 20(5):938-940. PubMed ID: 28949101
    [No Abstract]   [Full Text] [Related]  

  • 15. Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure.
    Packer M; McMurray JJV
    Lancet; 2017 May; 389(10081):1831-1840. PubMed ID: 27919443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ARNI, new abbreviation for a new class of treatment of heart failure].
    Karimzadeh S; Mustafić H; Stampfli Andres T
    Rev Med Suisse; 2017 Mar; 13(552):496-499. PubMed ID: 28714615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of RAAS-natriuretic peptides in the treatment of HF: Old guys and newcomers.
    Mollace V; Gliozzi M; Capuano A; Rossi F
    Int J Cardiol; 2017 Jan; 226():126-131. PubMed ID: 27075034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine activation as a target of modern chronic heart failure pharmacotherapy.
    Dobrek Ł; Thor P
    Acta Pol Pharm; 2011; 68(3):307-16. PubMed ID: 21648184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopeptidase inhibitors: will they have a role in clinical practice?
    Worthley MI; Corti R; Worthley SG
    Br J Clin Pharmacol; 2004 Jan; 57(1):27-36. PubMed ID: 14678337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natriuretic and antialdosterone actions of chronic oral NEP inhibition during progressive congestive heart failure.
    Martin FL; Stevens TL; Cataliotti A; Schirger JA; Borgeson DD; Redfield MM; Luchner A; Burnett JC
    Kidney Int; 2005 May; 67(5):1723-30. PubMed ID: 15840018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.